(S (NP (NNP EC) (ADJP (JJ funded)) (NN STriTuVaD) (NN project)) (VP (VBZ aims) (S (VP (TO to) (VP (VB test) (, ,) (PP (IN through) (NP (NP (DT a) (NN phase) (NN IIb)) (NP (JJ clinical) (NN trial)))) (, ,) (NP (NP (CD two)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ advanced)) (JJ therapeutic) (NNS vaccines)) (PP (IN against) (NP (NN tuberculosis)))))))))) (. .))
(S (PP (IN In) (ADJP (JJ parallel))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN extended) (NP (DT the) (NNP Universal) (NNP Immune) (NNP System) (NNP Simulator)) (S (VP (VP (TO to) (VP (VB include) (NP (NP (DT all) (JJ relevant) (NNS determinants)) (PP (IN of) (NP (JJ such) (JJ clinical) (NN trial)))))) (, ,) (VP (TO to) (VP (VB establish) (NP (PRP$ its) (JJ predictive) (NN accuracy)) (PP (IN against) (NP (NP (DT the) (JJ individual) (NNS patients)) (SBAR (S (VP (VP (VBD recruited) (PP (IN in) (NP (DT the) (NN trial))) (, ,) (S (VP (TO to) (VP (VB use) (S (NP (PRP it)) (VP (TO to) (VP (VB generate) (NP (JJ digital) (NNS patients))))))))) (CC and) (VP (VBP predict) (NP (PRP$ their) (NN response)) (PP (IN to) (NP (NP (DT the) (NNP HRT)) (VP (VBG being) (VP (VBN tested))))))))))))) (, ,) (CC and) (VP (TO to) (VP (VB combine) (NP (PRP them)) (PP (IN to) (NP (NP (DT the) (NNS observations)) (VP (VBN made) (PP (IN on) (NP (JJ physical) (NNS patients))) (S (VP (VBG using) (NP (DT a) (JJ new) (ADJP (ADJP (FW in) (FW silico)) (HYPH -) (VBN augmented)) (JJ clinical) (NN trial) (NN approach) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (DT a) (JJ Bayesian) (JJ adaptive) (NN design))))))))))))))))) (. .))
(S (NP (NP (DT This) (NN approach)) (, ,) (SBAR (WHADVP (WRB where)) (S (VP (VBN found) (S (ADJP (JJ effective))))))) (VP (MD could) (ADVP (RB drastically)) (VP (VB reduce) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NN innovation)))) (PP (IN in) (NP (NP (DT this) (JJ critical) (NN sector)) (PP (IN of) (NP (JJ public) (NN healthcare))))))) (. .))
(S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (JJ challenging)) (NN task)))) (VP (VBZ is) (S (VP (TO to) (VP (VB develop) (NP (DT a) (NN methodology) (S (S (VP (TO to) (VP (VB reproduce) (NP (NP (JJ biological) (NN diversity)) (PP (IN of) (NP (NP (DT the) (NNS subjects)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (S (VP (TO to) (VP (VB be) (VP (VBN simulated)))))))))))))) (, ,) (FW i.e.) (, ,) (S (VP (VB provide) (NP (DT an) (JJ appropriate) (NN strategy)) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (NNS libraries)) (PP (IN of) (NP (JJ digital) (NNS patients))))))))))))))) (. .))
(S (NP (DT This)) (VP (VBZ has) (VP (VBN been) (VP (VBN achieved) (PP (PP (IN through) (NP (NP (DT the) (DT the) (NN creation)) (PP (IN of) (NP (NP (DT the) (JJ initial) (JJ immune) (NN system) (NN repertoire)) (PP (IN in) (NP (DT a) (JJ stochastic) (NN way))))))) (, ,) (CC and) (PP (IN though) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT a) (`` ") (NN vector)) (PP (IN of) (NP (NP (NNS features)) ('' ") (SBAR (WHNP (WDT that)) (S (VP (VBZ combines) (NP (NP (DT both) (ADJP (JJ biological) (CC and) (JJ pathophysiological)) (NNS parameters)) (SBAR (WHNP (WDT that)) (S (VP (VBP personalize) (NP (DT the) (JJ digital) (NN patient)) (S (VP (TO to) (VP (VB reproduce) (NP (NP (DT the) (NN physiology)) (CC and) (NP (NP (DT the) (NN pathophysiology)) (PP (IN of) (NP (DT the) (NN subject))))))))))))))))))))))))) (. .))
